CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Gilead Sciences, Inc. Company Snapshot
Gilead Sciences, Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Gilead Sciences with three other pharmaceutical manufacturers in North America: DuPont de Nemours Inc (2020 sales of $20.40 billion of which 30% was Nutrition & Biosciences), Amgen Inc. ($25.42 billion of which 26% was Other products), and Eli Lilly and Company ($24.54 billion of which 29% was Oncology-Verzenio & Other).

Sales Analysis. Gilead Sciences reported sales of $24.69 billion for the year ending December of 2020. This represents an increase of 10.0% versus 2019, when the company's sales were $22.45 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Gilead Sciences, Inc.
  Stock Performance Chart for Gilead Sciences, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (4/30/2021): 63.47
(Figures in U.S. Dollars)
1 Week -3.1%   13 Weeks -4.5%  
4 Weeks -3.2%   52 Weeks -20.6%  
 
Gilead Sciences, Inc. Key Data:
  Ticker: GILD Country: United States
  Exchanges: NAS FRA MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 24,689,000,000
(Year Ending Jan 2021).
Employees: 13,600
  Currency: U.S. Dollars Market Cap: 79,591,380,000
  Fiscal Yr Ends: December Shares Outstanding: 1,254,000,000
  Share Type: Common Closely Held Shares: 1,402,085
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.